C2N Diagnostics
St. Louis, United States· Est.
Developing and accelerating novel diagnostics and therapies for Alzheimer’s disease. C2N new PrecivityAD™ blood test for Alzheimers disease. Diagnostic efforts revolve around bringing accurate, widely accessible, and cost-effective blood tests to the clinic for the betterment of patient care and br
Private Company
Funding information not available
About
Developing and accelerating novel diagnostics and therapies for Alzheimer’s disease. C2N new PrecivityAD™ blood test for Alzheimers disease. Diagnostic efforts revolve around bringing accurate, widely accessible, and cost-effective blood tests to the clinic for the betterment of patient care and br
DiagnosticsSmall Molecules